-+ 0.00%
-+ 0.00%
-+ 0.00%

Vaxcyte Q4 EPS $(1.80) Misses $(1.56) Estimate

Benzinga·02/24/2026 21:10:09
Listen to the news
Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(1.80) per share which missed the analyst consensus estimate of $(1.56) by 15.38 percent. This is a 76.47 percent decrease over losses of $(1.02) per share from the same period last year.